NO20061954L - Transgene dyr med alvorlige forstyrrelser relatert til Alzheimers sykdom - Google Patents

Transgene dyr med alvorlige forstyrrelser relatert til Alzheimers sykdom

Info

Publication number
NO20061954L
NO20061954L NO20061954A NO20061954A NO20061954L NO 20061954 L NO20061954 L NO 20061954L NO 20061954 A NO20061954 A NO 20061954A NO 20061954 A NO20061954 A NO 20061954A NO 20061954 L NO20061954 L NO 20061954L
Authority
NO
Norway
Prior art keywords
alzheimer
disease
transgenic animals
disorders related
severe disorders
Prior art date
Application number
NO20061954A
Other languages
English (en)
Other versions
NO334611B1 (no
Inventor
Patrick Benoit
Laurent Pradier
Veronique Blanchard-Bregeon
Caty Casas Louzao
Gunter Tremp
Jean-Michel Itier
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20061954L publication Critical patent/NO20061954L/no
Publication of NO334611B1 publication Critical patent/NO334611B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/107—Rabbit
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0312—Animal model for Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/02—Cells from transgenic animals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Oppfinnelsen angår ikke-humane transgene dyr med alvorlige forstyrrelser beslektet med Alzheimers sykdom. Dyrene kan anvendes for å påvise forbindelser som kan behandle Alzheimers sykdom.
NO20061954A 2003-10-02 2006-05-02 Transgent ikke-humant dyr med en nukleinsyresekvens som koder for presenilin 1 protein, celle eller cellelinje avledet fra dyret, mutert muse PS1- protein, nukleinsyre som koder for proteinet, vektor omfattende nukleinsyren, anvendelse av det transgene dyret for å påvise forbindelser til behandling av Alzheimers sykdom samt fremgangsmåte for å påvise forbindelsene NO334611B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0311578A FR2860391B1 (fr) 2003-10-02 2003-10-02 Animaux transgeniques presentant les troubles majeurs lies a la maladie d'alzheimer
PCT/FR2004/002436 WO2005032244A1 (fr) 2003-10-02 2004-09-27 Animaux transgeniques presentant les troubles majeurs lies a la maladie d'alzheimer

Publications (2)

Publication Number Publication Date
NO20061954L true NO20061954L (no) 2006-06-26
NO334611B1 NO334611B1 (no) 2014-04-22

Family

ID=34307379

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061954A NO334611B1 (no) 2003-10-02 2006-05-02 Transgent ikke-humant dyr med en nukleinsyresekvens som koder for presenilin 1 protein, celle eller cellelinje avledet fra dyret, mutert muse PS1- protein, nukleinsyre som koder for proteinet, vektor omfattende nukleinsyren, anvendelse av det transgene dyret for å påvise forbindelser til behandling av Alzheimers sykdom samt fremgangsmåte for å påvise forbindelsene

Country Status (22)

Country Link
EP (1) EP1670309B1 (no)
JP (1) JP4806635B2 (no)
KR (1) KR101164691B1 (no)
CN (1) CN1889826A (no)
AT (1) ATE471661T1 (no)
AU (1) AU2004277357B2 (no)
BR (1) BRPI0415032A (no)
CA (1) CA2540622C (no)
CY (1) CY1110788T1 (no)
DE (1) DE602004027823D1 (no)
DK (1) DK1670309T3 (no)
ES (1) ES2347961T3 (no)
FR (1) FR2860391B1 (no)
IL (1) IL174726A (no)
MX (2) MXPA06003670A (no)
NO (1) NO334611B1 (no)
PL (1) PL1670309T3 (no)
PT (1) PT1670309E (no)
RU (1) RU2373707C2 (no)
SI (1) SI1670309T1 (no)
WO (1) WO2005032244A1 (no)
ZA (1) ZA200602670B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2963791B1 (fr) * 2010-08-11 2012-09-21 Assist Publ Hopitaux De Paris Methode de diagnostic des maladies neurodegeneratives
WO2014007367A1 (ja) * 2012-07-05 2014-01-09 国立大学法人東京大学 同一試料中の２種の物質を検出又は測定する方法
JP6583011B2 (ja) * 2016-01-20 2019-10-02 コニカミノルタ株式会社 酸性水溶液を用いた免疫染色スライドの洗浄方法
CN109776665B (zh) * 2019-02-02 2021-02-05 首都医科大学宣武医院 阿尔茨海默病新突变、其稳转细胞模型及医药用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2798556B1 (fr) * 1999-09-17 2004-02-27 Aventis Pharma Sa Nouveau modele animal de la maladie d'alzheimer presentant a la fois des plaques amyloides et des dysfonctionnements mitochondriaux
CA2384865A1 (fr) * 1999-09-17 2001-03-29 Aventis Pharma S.A. Nouveau modele animal de la maladie d'alzheimer presentant a la fois des plaques amyloides et des dysfonctionnements mitochondriaux
EP1255437B1 (fr) * 1999-09-27 2010-04-14 Aventis Pharma S.A. Animal transgenique exprimant une forme multi-mutee de la preseniline 1
AU2001276995C1 (en) * 2000-07-20 2006-10-26 Cephalon, Inc. Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring

Also Published As

Publication number Publication date
DK1670309T3 (da) 2010-10-25
MXPA06003685A (es) 2006-06-20
JP4806635B2 (ja) 2011-11-02
AU2004277357A1 (en) 2005-04-14
FR2860391A1 (fr) 2005-04-08
KR20060090988A (ko) 2006-08-17
PL1670309T3 (pl) 2010-11-30
ZA200602670B (en) 2007-07-25
RU2006114692A (ru) 2007-11-10
CA2540622A1 (fr) 2005-04-14
IL174726A0 (en) 2006-08-20
IL174726A (en) 2013-05-30
RU2373707C2 (ru) 2009-11-27
ATE471661T1 (de) 2010-07-15
MXPA06003670A (es) 2006-06-20
CN1889826A (zh) 2007-01-03
WO2005032244A1 (fr) 2005-04-14
EP1670309A1 (fr) 2006-06-21
DE602004027823D1 (de) 2010-08-05
KR101164691B1 (ko) 2012-07-11
CA2540622C (fr) 2014-01-14
PT1670309E (pt) 2010-09-28
JP2007507217A (ja) 2007-03-29
ES2347961T3 (es) 2010-11-26
AU2004277357B2 (en) 2011-11-03
CY1110788T1 (el) 2015-06-10
NO334611B1 (no) 2014-04-22
SI1670309T1 (sl) 2010-11-30
EP1670309B1 (fr) 2010-06-23
BRPI0415032A (pt) 2006-12-12
FR2860391B1 (fr) 2006-01-27

Similar Documents

Publication Publication Date Title
DK1874282T3 (da) Fremgangsmåder og præparater til behandling af CNS lidelser
SE0202241D0 (sv) Novel Compounds
CY1109104T1 (el) 1,2,3,4 τετρα-υποκατεστημενη ινδολη για την αντιμετωπιση ασθενειων του αναπνευστικου
EA200802054A1 (ru) Ингибиторы фермента
ATE536349T1 (de) In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
MA33975B1 (fr) Composés et méthodes de modulation des kinases et leurs indications d'emploi
DK2527315T3 (da) Forbindelser, præparater og fremgangsmåder til behandling af amyloide sygdomme og synukleinopatier, såsom Alzheimers sygdom, type 2-diabetes og Parkinsons sygdom
EP1740559A4 (en) 1,3,5-SUBSTITUTED PHENYL DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
NO20026199L (no) Forbindelser for behandling av Alzheimers sykdom
SE0303180D0 (sv) Novel compounds
EP1756040A4 (en) PHENYL CARBOXAMIDE COMPOUNDS FOR USE AS BETA SECRETASE INHIBITORS IN THE TREATMENT OF ALZHEIMER'S DISEASE
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
EA200601607A1 (ru) Сульфонамидные соединения для лечения нейродегенеративных расстройств
DK1315506T3 (da) Phospholipidderivater af valproinsyre og blandinger deraf
ATE298568T1 (de) Albumin-bindende verbindungen die die nichtenzymatische glycosylierung verhindern und die zur behandlung von glycosylierungsbedingten erkrankungen verwendet werden können
DE602006014022D1 (de) 5-substituierte indol-2-carbonsäureamidderivate
NO20061954L (no) Transgene dyr med alvorlige forstyrrelser relatert til Alzheimers sykdom
ATE541923T1 (de) Transgener c. elegans als modellorganismus für untersuchungen zur alzheimer'schen krankheit
TW200505409A (en) Methods of inhibiting neurodegenerative disease
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
DE602005008417D1 (de) Pyrazolaminverbindungen zur behandlung neurodegenerativer erkrankungen
EA200701584A1 (ru) Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения
EA201070496A1 (ru) УГЛЕРОД-СВЯЗАННЫЕ МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ
ATE553114T1 (de) Verbindungen zur verminderung der aggregation von amyloid-beta-peptid
EA200701815A1 (ru) 6-гетероарил-1,2,3,4,4а,10в-гексагидрофенантридины в качестве pde-4 ингибиторов для лечения воспалительных заболеваний

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees